Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 2, 2014, Pages 171-177

  Chaux, Alcides ^a,c   Cubilla, Antonio L ^b   Haffner, Michael C ^a   Lecksell, Kristen L ^a   Sharma, Rajni ^a   Burnett, Arthur L ^a   Netto, George J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE PATOLOGÍA E INVESTIGACIÓN   (Paraguay)

^c Universidad del Norte School of Medicine   (Paraguay)

Author keywords

Human papillomavirus; In situ hybridization; P16INK4a; Penile cancer; Sensitivity and specificity; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

AREA UNDER THE CURVE; CANCER MORPHOLOGY; CANCER TISSUE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PENILE SQUAMOUS CELL CARCINOMA; PENIS CARCINOMA; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

HUMAN PAPILLOMAVIRUS; IN SITU HYBRIDIZATION; P16(INK4A); PENILE CANCER; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 84892521674     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.04.017     Document Type: Review

References (17)

1. Backes D.M., Kurman R.J., Pimenta J.M., et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009, 20:449-457.
2. Miralles-Guri C., Bruni L., Cubilla A.L., et al. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009, 62:870-878.
3. Cubilla A.L., Lloveras B., Alejo M., et al. Value of p16INKα in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases. Am J Surg Pathol 2011, 35:253-261.
4. Cubilla A.L., Lloveras B., Alejo M., et al. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: A study of 202 cases from Paraguay. Am J Surg Pathol 2010, 34:104-114.
5. Rubin M.A., Kleter B., Zhou M., et al. Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001, 159:1211-1218.
6. Gregoire L., Cubilla A.L., Reuter V.E., et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995, 87:1705-1709.
7. Epstein J.H., Cubilla A.L., Humphrey P.A. Tumors of the Prostate Gland, seminal vesicles, penis, and scrotum. Atlas of Tumor Pathology 2011, 405-612. Armed Forces Institute of Pathology, Washington, D.C.
8. Castellsagué X., Bosch F.X., Muñoz N., et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002, 346:1105-1112.
9. Castellsagué X., Bosch F.X., Muñoz N. The male role in cervical cancer. Salud Publica Mex 2003, 45(Suppl 3):S345-S353.
10. Shariat S.F., Zlotta A.R., Ashfaq R., et al. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 2007, 20:445-459.
11. Shariat S.F., Tokunaga H., Zhou J., et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 2004, 22:1014-1024.
12. Yavuzer D., Karadayi N., Salepci T., et al. Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol 2011, 28:919-923.
13. Ben Selma W., Ziadi S., Ben Gacem R., et al. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract 2010, 206:740-743.
14. Cai T., Mazzoli S., Meacci F., et al. Human papillomavirus and non-muscle invasive urothelial bladder cancer: Potential relationship from a pilot study. Oncol Rep 2011, 25:485-489.
15. Higgins J.P., Kaygusuz G., Wang L., et al. Placental S100 (S100P) and GATA3: Markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007, 31:673-680.
16. Kaufmann O., Volmerig J., Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000, 113:683-687.
17. Parker D.C., Folpe A.L., Bell J., et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 2003, 27:1-10.